Shuji Joho Selected Research

Shuji Joho Research Topics

Disease

17	Heart Failure 08/2022 - 12/2002
4	Pulmonary Arterial Hypertension 12/2023 - 05/2016
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2019
3	Cardiomyopathies (Cardiomyopathy) 07/2020 - 12/2002
2	Pericardial Effusion 04/2022 - 07/2002
2	Neoplasms (Cancer) 04/2022 - 02/2006
2	Myocardial Infarction 01/2011 - 04/2006
1	Muscle Weakness 01/2024
1	Dyspnea (Shortness of Breath) 01/2024
1	Liver Neoplasms (Liver Cancer) 01/2024
1	Hepatocellular Carcinoma (Hepatoma) 01/2024
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2024
1	Myocarditis (Carditis) 01/2024
1	Myasthenia Gravis 01/2024
1	Cardiac Tamponade 04/2022
1	Hemangiosarcoma (Angiosarcoma) 04/2022
1	Systolic Heart Failure 01/2022
1	Pulmonary Hypertension 01/2022
1	Hypotension (Low Blood Pressure) 10/2021
1	Sleep Apnea Syndromes (Sleep Apnea) 09/2019
1	Clinical Deterioration 05/2016
1	Atrial Fibrillation 01/2012
1	Hypertrophy 02/2009
1	Infections 11/2004
1	Hypoxia (Hypoxemia) 11/2004
1	Infarction (Infarctions) 11/2004
1	Tachycardia (Tachyarrhythmias) 12/2002
1	Heart Rupture 07/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2002
1	Angina Pectoris 02/2002
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2002
1	Coronary Occlusion 02/2002
1	Ischemia 02/2002

Drug/Important Bio-Agent (IBA)

5	Sodium-Glucose Transport ProteinsIBA 08/2022 - 01/2021
3	Sodium-Glucose Transporter 2 InhibitorsIBA 08/2022 - 07/2021
2	SodiumIBA 01/2022 - 09/2019
2	Endothelin Receptor AntagonistsIBA 01/2020 - 05/2016
2	macitentanIBA 01/2020 - 05/2016
2	CanagliflozinIBA 09/2019 - 12/2017
2	Dobutamine FDA LinkGeneric 12/2017 - 12/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2006 - 11/2004
1	atezolizumabIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Hemoglobins (Hemoglobin)IBA 04/2022
1	selexipagIBA 01/2022
1	Serum AlbuminIBA 01/2022
1	Epoprostenol ReceptorsIBA 01/2022
1	isoxanthopterinIBA 11/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2021
1	Enalapril FDA LinkGeneric 10/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2021
1	Neprilysin (Neutral Endopeptidase)IBA 10/2021
1	Amyloid (Amyloid Fibrils)IBA 07/2020
1	Prealbumin (Transthyretin)IBA 07/2020
1	tafamidisIBA 07/2020
1	Oxygen (Dioxygen)IBA 09/2019
1	Glucose (Dextrose)FDA LinkGeneric 09/2019
1	empagliflozinIBA 09/2019
1	dapagliflozinIBA 09/2019
1	Uric Acid (Urate)IBA 01/2019
1	DiureticsIBA 12/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2016
1	fibrin fragment D (D-dimer)IBA 01/2012
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 02/2009
1	Antihypertensive Agents (Antihypertensives)IBA 04/2006
1	LipidsIBA 04/2006
1	Proteins (Proteins, Gene)FDA Link 06/2005
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2004
1	Cardiac MyosinsIBA 11/2004
1	Indicators and Reagents (Reagents)IBA 10/2004
1	pimobendanIBA 12/2002
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 07/2002
1	Iodine-123IBA 02/2002

Therapy/Procedure

6	Therapeutics 12/2023 - 07/2002
1	Sternotomy 04/2022
1	Endarterectomy (Thromboendarterectomy) 01/2022
1	Continuous Positive Airway Pressure 01/2014
1	Denervation 02/2002
1	Sympathectomy (Sympathectomies) 02/2002